In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 128 for your search:
Drug:  anti-thymocyte globulin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MSGCC-9721, NCI-V98-1438

2.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: SMD/ATG-CSA/2002, NCT00488436

3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 50 and under
Sponsor: Other
Protocol IDs: CDR0000066400, MSGCC-9739, NCI-V98-1433, NCT00003398

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: Under 46
Sponsor: Other
Protocol IDs: UMN-MT-1995-06, UMN-9224, UMN-MT-9506, NCI-V00-1605, NCT00006451

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 4 to 70
Sponsor: Other
Protocol IDs: CDR0000066968, RP 98-15, RPCI-RP-9815, NCI-V99-1527, NCT00003816

6.

Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 12 to 50
Sponsor: Other
Protocol IDs: CHIMERIC-HM01, WSU-10-02-99-M01-FB, NCT00004255

7.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 35 and under
Sponsor: Other
Protocol IDs: MT2000-18, 9504M09637, NCT00176878

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: EudraCT:2005-000805-68, NCT00354120

9.

Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 1 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ABX-CB-9906, UCLA-9911052, NCI-G01-1916, NCT00012077, NCT00035880

10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: SAKK 33/99, SWS-SAKK-33/99, NCT00004208

11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 5 to 55 preferred
Sponsor: NCI
Protocol IDs: MSKCC-93045, NCI-H93-0293, NCT00002534

12.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Under 18
Sponsor: Other
Protocol IDs: CCLG-LCH-2006-02, EU-20619, UKCCSG-HLH-2004, EUDRACT-2005-002187-28, NCT00334672

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 30
Sponsor: NCI, Other
Protocol IDs: AAML0531, COG-AAML0531, CDR0000487497, NCT00372593

14.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 12 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: PROGAST, NCT00180089

15.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 65 and under
Sponsor: Other
Protocol IDs: 2005-0366, NCT00469144

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 3 months to 18 years
Sponsor: Other
Protocol IDs: EudraCT 2005-005106-23, NCT01423500

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 3 months to 18 years
Sponsor: Other
Protocol IDs: ALL-SZT- BFM 2003, NCT01423747

18.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 55 and below
Sponsor: NCI
Protocol IDs: FHCRC-1126.00, NCI-V97-1211

19.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 17 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: CP-0134-004, NCI-V97-1219

20.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 55 and under
Sponsor: NCI
Protocol IDs: FHCRC-1127.00, NCI-G97-1230

21.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: GCLLSG-CLL3X, EU-20554, MEDAC-FLUD.10/CLL, NCT00281983

22.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 17 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000462443, UCSF-01152, UCSF-H411-17802-06, NCT00305708

23.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 70 and under
Sponsor: Other
Protocol IDs: 2005-0508, NCI-2012-01484, 1PO1CA100265, NCT00402558

24.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 65 and under
Sponsor: NCI, Other
Protocol IDs: 383, U01HL069294, BMT CTN 0301, 5 U01 HL69294-05, FHCRC-2051.00, NCT00326417

25.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: EK126092000, NCT00460629
1     
New Search